Alerts will be sent to your verified email
Verify Email
CHEMOPH
|
Chemo Pharma Labs
|
Phaarmasia
|
Hamps Bio
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-4.51 % | -4.64 % | 17.75 % |
|
5yr average Equity Multiplier
|
1.01 | 2.31 | 2.66 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.88 | 1.39 |
|
5yr Avg Net Profit Margin
|
0.0 | -2.3 % | 5.48 % |
|
Price to Book
|
1.46 | 2.01 | 0.0 |
|
P/E
|
51.02 | 0.0 | 36.97 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -185.24 Days | 10.22 Days |
|
Inventory Days
|
0.0 | 80.36 Days | 38.15 Days |
|
Days Receivable
|
0.0 | 92.79 Days | 49.29 Days |
|
Days Payable
|
0.0 | 365.75 Days | 79.37 Days |
|
5yr Average Interest Coverage Ratio
|
794.39 | -67.17 | 3.3 |
|
5yr Avg ROCE
|
-3.17 % | -3.88 % | 22.28 % |
|
5yr Avg Operating Profit Margin
|
0.0 | -3.07 % | 15.08 % |
|
5 yr average Debt to Equity
|
0.01 | 0.0 | 1.2 |
|
5yr CAGR Net Profit
|
n/a | n/a | 33.03 % |
|
5yr Average Return on Assets
|
-4.13 % | -2.07 % | 7.45 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
27.89 % | 73.51 % | 71.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Chemo Pharma Labs
|
Phaarmasia
|
Hamps Bio
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|